explore -WSS

explore

author：leisure time 2025-09-03 14:35:50 - browse：878

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

WSS

6 phony surgeries that take placebo to the extreme

Alabama hospital puts IVF treatments on hold

Abortion pill Supreme Court ruling could impact entire drug industry

Study says nonprofit hospitals fall short in charity care spending

Obesity drugs seen as possible treatment for liver disease MASH

Dario to buy mental health app maker Twill in cash and stock deal

hotspot

explore

focus

Peter Hotez and the public health issue of online harassment

The Readout: Lenmeldy, GLP

Walensky prepares to leave CDC — and Congress — behind

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Tori Bowie and the unacceptable rates of Black maternal death

Community Health Systems hospitals under DOJ investigation

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

What does generative AI mean for health care? We asked experts

Decaf coffee targeted by food safety group under obscure FDA rule

entertainment

With competition flaring, obesity drug hits goal in liver disease study

PBM reform efforts get punted in Congress

NIH study of ME/CFS points to clear biological hallmarks

Scientists boost immune system in aging mice by making it youthful

A new nitrogen execution bill also undermines medical licensing

A solution to the after

entertainment

focus

entertainment

hotspot